14 Patents
- US126053812026Method for Treating Endometriosis-associated Pain by Using Diaminopyrimidine Compound
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US125826532026Method for Treating Idiopathic Pulmonary Fibrosis
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US1254438220262, 4, 6-tri-substituted Pyrimidine Compound as ATR Kinase Inhibitor
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US125094792025P2X3 And/or P2X2/3 Receptor Antagonist, Pharmaceutical Composition Comprising Same, and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US124851082025Method for Treating Fatty Liver Disease And/or Steatohepatitis
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US124101922025Compound for Inhibiting and Inducing Degradation of EGFR Kinase
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US123981182025Rho-associated Protein Kinase Inhibitor, Pharmaceutical Composition Comprising Same, and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US121802432024Receptor Inhibitor, Pharmaceutical Composition Comprising Same, and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US121758822024Hands-on Laboratory and Demonstration Equipment with a Hybrid Virtual/augmented Environment, Along with Their Methods of Use
The Trustees Of The California State University
0 cites - US119395782024Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US119199182024P2X3 Andor P2X2/3 Receptor Antagonist, Pharmaceutical Composition Comprising Same, and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - US119052742024Receptor Inhibitors, Pharmaceutical Compositions Comprising the Same and Use Thereof
BEIJING TIDE PHARMACEUTICAL CO., Ltd.
0 cites - USD09974942023Skirt0 cites
- US116945752023Hands-on Laboratory and Demonstration Equipment with a Hybrid Virtual/augmented Environment, Along with Their Methods of Use
The Trustees Of The California State University
0 cites